Gastric bypass surgery tied to diabetes remission

(Reuters Health) – Three in four obese people with diabetes who had a common type of weight-loss operation called Roux-en-Y gastric bypass (RYGB) experienced remission of their diabetes within a year after surgery, a Danish study found.

FILE PHOTO: A man crosses a main road as pedestrians carrying food walk along the footpath in central Sydney, Australia, August 12, 2015. REUTERS/David Gray

Five years later, 27 percent of the people who achieved remission had relapsed, the study also found. However, the total proportion of people in remission held steady, suggesting that some people achieved remission later and remained free of diabetes symptoms.

“We have known for some years from smaller studies . . . that Roux-en-Y gastric bypass surgery has the ability to make type 2 diabetes go into remission, meaning freeing patients from the use of glucose-lowering drugs,” said lead study author Dr. Lene Ring Madsen of Aarhus University in Denmark.

“The novelty of our study is that we can confirm these results in large real-world cohorts of unselected patients with severe obesity and type 2 diabetes,” Madsen said by email.

Gastric bypass reduces the size of the stomach from about three pints to roughly the size of a shot glass.

In the current study, researchers examined data on 1,111 people with type 2 diabetes, the more common form that’s associated with obesity and aging. All the patients had Roux-en-y gastric bypass procedures between 2006 and 2015.

Patients were more likely to achieve diabetes remission after surgery when they were younger, had been living with diabetes for shorter periods of time, and had less severe diabetes. Men also did better than women.

Within six months of surgery, 65 percent of patients had their diabetes go into remission. This rate rose to 74 percent over the next six months and remained there for the rest of the study period.

Diabetics who were taking insulin before their weight-loss surgery had 43 percent lower remission rates than patients who didn’t need insulin, the study also found.

Compared to 1,074 similar obese patients with type 2 diabetes who didn’t have RYGB surgery, those who did were less likely to develop so-called microvascular complications like kidney or eye problems caused by diabetes. With surgery, the risk of eye damage was 48 percent lower and the chance of kidney disease was 46 percent lower.

Within 30 days of surgery, 7.5 percent of patients had repeat hospitalizations for complications related to the gastric bypass procedures.

The study, reported in Diabetologia, wasn’t a controlled experiment designed to prove whether or how weight-loss surgery might help people control diabetes symptoms or reduce the need for diabetes medications.

Even so, the results suggest that obese people with diabetes may not necessarily want to wait to have surgery if they’re considering this option, since their chance of remission goes down the longer they live with diabetes, said Dr. Sheri Colberg of Old Dominion University in Norfolk, Virginia.

“The earlier after diabetes diagnosis that gastric bypass surgery is done, the greater its potential impact on preventing many diabetes-related health complications,” Colberg, who wasn’t involved in the study, said by email.

“Given that it involves major abdominal surgery, having a gastric bypass procedure is certainly not without some major health risks, including short-term complications from the surgery itself and longer-term ones like micronutrient deficiencies due to malabsorption of vitamins and minerals in the diet,” Colberg added.

“This study does suggest that more than half of patients undergoing such surgeries were able to remain diabetes-free, which reduces their risk of the long-term health complications associated with diabetes,” Colberg said. “Patients who are unable to lose weight any other way may benefit more than those who can lose weight (and reverse diabetes or limit its impact) via adopting a healthier lifestyle — it will need to be an individual choice and is certainly not for everyone.”

SOURCE: bit.ly/2UePjdZ Diabetologia, online February 6, 2019.

Source

more recommended stories

  • Senator Gillibrand wants insurance to pay for fertility treatments

    WASHINGTON (Reuters) – U.S. Democratic presidential.

  • Hundreds rally at U.S. Supreme Court, calling state abortion bans as step backward

    WASHINGTON (Reuters) – Abortion-rights campaigners, including.

  • French court says doctors must resume life support for paralyzed patient

    STRASBOURG, France (Reuters) – A French.

  • Missouri follows Alabama by passing restrictive abortion bill

    (Reuters) – Missouri lawmakers passed a.

  • Too much screen time tied to school problems even in little kids

    (Reuters Health) – Kindergarteners who get.

  • Smokers have higher risk for multiple strokes

    (Reuters Health) – Smokers who have.

  • Missouri assembly passes restrictive abortion bill, days after Alabama

    (Reuters) – The lower house of.

  • Missouri Senate passes bill to ban abortions after eight weeks

    (Reuters) – Missouri’s Senate passed a.

  • Alabama governor signs strictest U.S. abortion ban into law

    (Reuters) – Alabama’s governor signed a.

  • Alabama Senate bans nearly all abortions, including rape cases

    (Reuters) – Alabama’s state Senate passed.

  • Israel regulator warns of medical cannabis bubble, eyes Australia pact

    JERUSALEM (Reuters) – Medical cannabis could.

  • U.S. measles outbreak grows with 75 new cases, mostly in New York

    (Reuters) – U.S. health authorities recorded.

  • Teva Pharm CFO says company did not conspire to fix prices

    FILE PHOTO: The logo of Teva.

  • U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit

    WASHINGTON (Reuters) – U.S. states filed.

  • Exclusive: Philip Morris suspends social media campaign after Reuters exposes young ‘influencers’

    (Reuters) – Cigarette maker Philip Morris.

  • Hong Kong reports African swine fever case

    HONG KONG (Reuters) – Hong Kong.

  • Alabama Senate delays vote on strict anti-abortion bill

    (Reuters) – Alabama’s state Senate on.

  • Denver votes to become first U.S. city to decriminalize ‘magic mushrooms’

    Psilocybin or “magic mushrooms” are seen.

  • AstraZeneca-Daiichi Sankyo breast cancer drug shows promise

    The company logo for pharmaceutical company.

  • Denver to vote on decriminalizing ‘magic mushrooms’

    FILE PHOTO: Boxes containing magic mushrooms.

  • Trans teens face higher sexual assault risk when schools restrict bathrooms

    (Reuters Health) – Transgender adolescents may.

  • U.S. doctors use medical records to fight measles outbreak

    CHICAGO (Reuters) – U.S. doctors are.

  • UK’s Vectura wins patent infringement case against GlaxoSmithKline in U.S

    (Reuters) – British drugmaker Vectura Group.

  • Tyson Foods recalls almost 12 million pounds of chicken strips over contamination fears

    (Reuters) – Tyson Foods Inc significantly.

  • Monstrous rumors stoke hostility to Pakistan’s anti-polio drive

    PESHAWAR, Pakistan (Reuters) – His bearded.

  • U.S. health agency finalizes conscience and religious freedom rule

    WASHINGTON (Reuters) – The U.S. Department.

  • Medication use drops when local drugstores close

    (Reuters Health) – People are less.

  • EPA says popular weed killer glyphosate is not a carcinogen

    CHICAGO (Reuters) – The U.S. Environmental.

  • Novartis’s Sandoz strikes deal for biosimilar of Herceptin

    FILE PHOTO: Swiss drugmaker Novartis’ logo.

  • U.S. measles outbreak triggers quarantine at two Los Angeles universities

    LOS ANGELES (Reuters) – A nationwide.

  • U.S. measles outbreak raises questions about immunity in adults

    (Reuters) – Adults in the United.

  • FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug

    (Reuters) – The U.S. Food and.